Target intelligence / Profile preview

microRNA 632 (miR-632)

Target
miR-632
Molecular classification
microRNA, Non-coding RNA, Gene regulator
01

Overview

miR-632 is a human microRNA molecule (~20–24 nucleotides) involved in the post-transcriptional regulation of gene expression[5]. It regulates genes primarily by targeting and silencing their transcripts through base pairing, affecting both transcript stability and protein translation[5][2]. One key target is DNAJB6, a member of the heat shock protein family involved in cell stress response and suppression of epithelial-to-mesenchymal transition; miR-632-mediated DNAJB6 inhibition is linked to cancer progression and vessel wall degeneration in Marfan syndrome[1][2]. Clinically, miR-632 has emerged as a promising biomarker for myelodysplastic syndromes and as a potential therapeutic target in cancer and vascular disease[1][2].

Other names
hsa-mir-632MIR632MIRN632
02

Mechanism of action

Modulation of gene expression by binding mRNA and inhibiting translation or destabilizing the transcript; Inhibition of DNAJB6 leading to Wnt/β-catenin pathway activation

03

Biological functions

Regulation of gene expressionPost-transcriptional gene silencingCell differentiation (via endothelial-to-mesenchymal and epithelial-to-mesenchymal transitions)Fibrosis regulation
04

Disease associations

Cancer (especially breast cancer)Marfan syndrome / thoracic aortic aneurysmsMyelodysplastic syndromes (MDS)
05

Safety considerations

Off-target effects common with miRNA-based therapeuticsPathway pleiotropy (miR-632 regulates multiple genes, increasing risk of unintended consequences in gene networks)
06

Biomarkers

miR-632 levels (potential diagnostic marker for myelodysplastic syndromes, differential marker in Marfan syndrome thoracic aortic aneurysms)

Beyond the preview

Go deeper on microRNA 632 (miR-632).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 632 (miR-632).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call